I believe that competition is an important part of the tendering process as interested manufacturers bid for molecules.  The winner of the tender will immediately see increases in volume, which will provide efficiencies of scale and support the low price.  In New Zealand there is an important clause in the tender agreement that manufacturers must warn Pharmac of impending shortages or risk future opportunities to tender other molecules.